# Obstructive Sleep Apnea (OSA) and Sex-Specific Responses to N-acetylcysteine (NAC)

> **NCT06311045** · NA · ACTIVE_NOT_RECRUITING · sponsor: **NYU Langone Health** · enrollment: 14 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DIETARY_SUPPLEMENT:** N-acetylcysteine (NAC)
- **DIETARY_SUPPLEMENT:** Placebo
- **PROCEDURE:** Positive Airway Pressure (PAP) Therapy

## Key facts

- **NCT ID:** NCT06311045
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-07
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06311045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06311045, "Obstructive Sleep Apnea (OSA) and Sex-Specific Responses to N-acetylcysteine (NAC)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06311045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*